Monoclonal Gammopathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2020-09-21
Clinical Trial Update: Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat [Phase 4]
A Phase 4 trial investigating antigen-lipid–driven monoclonal gammopathies targeting epicardial fat has been withdrawn.